What Are the Major Indications for Apresoline? A Comprehensive Guide
•
4 min read
Apresoline, also known by its generic name hydralazine, was initially patented in 1949 and approved by the FDA in 1953. Although the brand name is no longer marketed in the U.S., generic hydralazine remains a vital vasodilator used to manage specific cardiovascular conditions where its powerful effect is most beneficial.